Active	Status	Sponsor type	Region	Phase	Filter
5 Active 4 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Caldera, Freddy
NCT03798691: Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab	Completed	4	33	US	Shingrix, Recombinant zoster vaccine	University of Wisconsin, Madison, Boston Medical Center	Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Herpes Zoster	10/23	09/24
NCT06224270: Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications	Withdrawn	4	264	US	Adjuvanted Recombinant Zoster Vaccine (RZV)	University of Wisconsin, Madison, GlaxoSmithKline	Inflammatory Bowel Diseases, IBD	09/27	09/27
NCT06027229: Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations	Active, not recruiting	2	21	US	NVX-CoV2372, Novavax COVID-19 Vaccine	University of Wisconsin, Madison, Novavax	Immunosuppression, COVID-19	03/25	03/25
NCT05014555: Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease	Not yet recruiting	N/A	400	US	COVID-19 Vaccine	GI Alliance, Janssen, LP, University of Wisconsin, Madison, Mayo Clinic	Inflammatory Bowel Diseases	01/24	01/24
NCT05584735: Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine	Recruiting	N/A	60	US	Influenza vaccine, COVID-19 vaccine	University of Wisconsin, Madison	Inflammatory Bowel Diseases	09/25	09/25
Leudke, Lindsey
No trials found